{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T15:48:44Z","timestamp":1756309724212,"version":"3.37.3"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T00:00:00Z","timestamp":1649721600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,8]]},"DOI":"10.1093\/ecco-jcc\/jjac042","type":"journal-article","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T20:16:34Z","timestamp":1647461794000},"page":"1343-1344","source":"Crossref","is-referenced-by-count":1,"title":["COVID-19 Vaccines in IBD Patients: Particularities and Future Perspectives"],"prefix":"10.1093","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2634-9668","authenticated-orcid":false,"given":"Fernando","family":"Magro","sequence":"first","affiliation":[{"name":"Department of Biomedicine, Unit of Pharmacology and Therapeutics, Faculty of Medicine, University of Porto , Porto , Portugal"},{"name":"Department of Gastroenterology, S\u00e3o Jo\u00e3o Hospital Center , Porto , Portugal"},{"name":"Clinical Pharmacology Unit, S\u00e3o Jo\u00e3o Hospital University Center , Porto , Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7171-0139","authenticated-orcid":false,"given":"Maria Manuela","family":"Estevinho","sequence":"additional","affiliation":[{"name":"Department of Biomedicine, Unit of Pharmacology and Therapeutics, Faculty of Medicine, University of Porto , Porto , Portugal"},{"name":"Department of Gastroenterology, Vila Nova de Gaia\/Espinho Hospital Center , Vila Nova de Gaia , Portugal"}]}],"member":"286","published-online":{"date-parts":[[2022,4,12]]},"reference":[{"key":"2022090816393986800_CIT0001","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/ecco-jcc\/jjab147","article-title":"T cell","volume":"16","author":"Reuken","year":"2022","journal-title":"J Crohns Colitis"},{"key":"2022090816393986800_CIT0002","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2021.04.025","article-title":"Serologic response to messenger RNA Coronavirus Disease 2019 vaccines in inflammatory bowel disease patients receiving biologic therapies.","volume":"161","author":"Wong","year":"2021","journal-title":"Gastroenterology"},{"journal-title":"J Crohns Collitis","article-title":"Implementation and short-term adverse events of anti-SARS-CoV-2 vaccines in inflammatory bowel disease patients: an international web-based survey.","author":"Ellul","key":"2022090816393986800_CIT0003"},{"journal-title":"J Crohns Colitis","article-title":"Reduced serological response to COVID-19 vaccines in patients with IBD is further diminished by TNF inhibitor therapy; Early results of the VARIATION study [VAriability in Response in IBD Against SARS-COV-2 ImmunisatiON].","author":"Doherty","key":"2022090816393986800_CIT0004"},{"key":"2022090816393986800_CIT0005","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1053\/j.gastro.2021.08.014","article-title":"Decreased antibody responses to Ad26.COV2.S relative to SARS-CoV-2 mRNA vaccines in patients with inflammatory bowel disease.","volume":"161","author":"Pozdnyakova","year":"2021","journal-title":"Gastroenterology"},{"key":"2022090816393986800_CIT0006","doi-asserted-by":"crossref","first-page":"462","DOI":"10.14309\/ajg.0000000000001619","article-title":"Factors affecting initial humoral immune response to SARS-Cov-2 vaccines among patients with inflammatory bowel diseases.","volume":"117","author":"Kappelman","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"2022090816393986800_CIT0007","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1136\/gutjnl-2021-324789","article-title":"Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD.","volume":"70","author":"Kennedy","year":"2021","journal-title":"Gut"},{"key":"2022090816393986800_CIT0008","article-title":"Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in infliximab- and vedolizumab-treated patients.","author":"Lin","year":"2021","journal-title":"medRxiv"},{"journal-title":"Arthritis Rheumatol","article-title":"Rituximab impairs B-cell response but not T-cell response to COVID-19 vaccine in auto-immune diseases.","author":"Bitoun","key":"2022090816393986800_CIT0009"},{"key":"2022090816393986800_CIT0010","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S2468-1253(21)00374-5","article-title":"Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease.","volume":"6","author":"Alexander","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/advance-article-pdf\/doi\/10.1093\/ecco-jcc\/jjac042\/43369868\/jjac042.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/16\/9\/1343\/45747584\/jjac042.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/16\/9\/1343\/45747584\/jjac042.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T16:40:25Z","timestamp":1662655225000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article\/16\/9\/1343\/6567366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,12]]},"references-count":10,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,4,12]]},"published-print":{"date-parts":[[2022,9,8]]}},"URL":"https:\/\/doi.org\/10.1093\/ecco-jcc\/jjac042","relation":{},"ISSN":["1873-9946","1876-4479"],"issn-type":[{"type":"print","value":"1873-9946"},{"type":"electronic","value":"1876-4479"}],"subject":[],"published-other":{"date-parts":[[2022,9,1]]},"published":{"date-parts":[[2022,4,12]]}}}